JMKX-003948

N/A

Report date: 2024/12/12 15:04:20
NME

Base Information

Drug NameJMKX-003948
Drug Alias NameJMKX-003948
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic macular oedemaRetinal Vein OcclusionWet age-related macular degeneration +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangxi Jemincare Group Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhejiang Hangyu Pharmaceutical Co LtdShanghai Jiyu Pharmaceutical Technology Co LtdJiangxi Jemincare Group Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaRetinal Vein OcclusionWet age-related macular degeneration +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A